James Warren Tea Limited (JAMESWARREN) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹972M
Fair value as of: Jul 5, 2026
From 22 valuation models · updated today
Share price −4.4% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹249.65 – ₹378.55 · fair‑value band ₹241.25 – ₹456.91 · the ₹262.80 price screens below the ₹365.53 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
James Warren Tea Limited (JAMESWARREN) currently trades at ₹262.80, while our model-based Fair Value estimate is ₹365.53 — implying the stock looks roughly 39.1% undervalued today. We read business quality at 46/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, James Warren Tea Limited generated revenue of ₹1.1B at a net margin of 11.2%. Revenue declined 60.2% year over year. It earns a return on equity of 6.4%. The stock trades on a trailing P/E of 7.8. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹241.25 (bear case) to ₹456.91 (bull case); at ₹262.80, the current price sits within that range. The share trades about 36% below its 52-week high and 6% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at 40% fair-value upside — at 39%, JAMESWARREN screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
About the company
James Warren Tea Limited engages in cultivation, manufacture and sale of tea in India. It primarily offers CTC and orthodox tea products. The company operates seven tea estates located in the South Bank, Upper Assam. It exports its products to Europe, the United Kingdom, the United States, Japan, China, Commonwealth of Independent States, and the Middle East. The company was formerly known as Dashabhooja Mercantile & Tourism Private Limited. James Warren Tea Limited was founded in 1850 and is based in Kolkata, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
James Warren Tea Limited reported revenue of ₹1.1B in FY2026 versus ₹1.1B in FY2022, a compound +0.8%/yr. Reported net income was ₹124M in FY2026, compounding +10.8%/yr from FY2022.
Is JAMESWARREN fairly valued? → Check now
Similar stocks
10 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jul 5, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Archer-Daniels-Midland Company ADM | $76.29 | $46.97 | -38% |
| Muyuan Foods Group 002714 | ¥35.06 | ¥49.23 | +40% |
| Bunge Global SA BG | $128.21 | $88.65 | -31% |
| Wens Foodstuff Group 300498 | ¥12.83 | ¥7.44 | -42% |
| Mowi ASA MOWI | kr 190.10 | kr 134.90 | -29% |
| SalMar ASA SALM | kr 574.50 | kr 57.93 | -90% |
| Fujian Wanchen Food Group 300972 | ¥179.40 | ¥323.13 | +80% |
| PT Charoen Pokphand Indonesia Tbk, CPIN | 3,170 IDR | 7,228 IDR | +128% |
| New Hope Liuhe Co 000876 | ¥6.58 | ¥24.03 | +265% |
| Charoen Pokphand Foods Public Company CPF | 18.80 THB | 39.37 THB | +109% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is James Warren Tea Limited (JAMESWARREN) undervalued?
What is the fair value of JAMESWARREN?
What is the quality score of JAMESWARREN?
What is the revenue of James Warren Tea Limited (JAMESWARREN)?
What is the net profit margin of JAMESWARREN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.